Tina Bernardi
Acute Care · Oak Lawn, ILNPI 1235597485
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $594 and has fallen 91.1% since, to $53 in 2025.
Across 84 payments — averaging $22.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$436
- Johnson & Johnson$331
- Boehringer Ingelheim$183
- Novartis$154
- Amarin Pharma, Inc.$140
- Amgen$121
- plus $528 from 13 others
What the payments were for
- Food & beverage$1,892100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$315
How this compares
$1,892 in reported general payments places this provider in the 85th percentile of 461 acute care providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 58 | $82,189 |
| EntrestoSacubitril/Valsartan | 28 | $28,014 |
| XareltoRivaroxaban | 17 | $26,833 |
| Nebivolol Hcl | 32 | $3,293 |
| Metoprolol Succinate | 180 | $2,625 |
| Ranolazine ErRanolazine | 11 | $1,155 |
| Atorvastatin Calcium | 123 | $1,126 |
| Amiodarone Hcl | 33 | $885 |
| Nifedipine ErNifedipine | 18 | $770 |
| Potassium Chloride | 27 | $673 |
| Lisinopril | 76 | $671 |
| Losartan Potassium | 55 | $650 |
| Ezetimibe | 16 | $628 |
| Pravastatin Sodium | 15 | $600 |
| Rosuvastatin Calcium | 51 | $498 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $154 | $28,01428 claims |
| Johnson & JohnsonXarelto | $331 | $26,83317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 461 acute care providers in Illinois.
Other acute care in Oak Lawn
- Laura CoyleOak Lawn$34K
- Marissa NewtoffOak Lawn$4K
- Brittany SegrestOak Lawn$3K
- Tedra GrayChicago$78K
- Lynn HickmanArlington Heights$61K
- Gwen CassidyChicago$46K
- Erin DarguzasChicago$17K
- Amy BatesQuincy$14K
- Sarah MiyataChicago$11K
- Katie MeadorChicago$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.